Navigation Links
MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
Date:11/22/2011

SAN DIEGO, Nov. 22, 2011 /PRNewswire/ -- MedVantx, Inc., today announced the deployment of its patent pending Patient Profile™ patient medication and adherence reporting engine across its network of 3,600 high prescribing primary care providers participating in the Company's integrated program of initial free medication therapy, adherence management and home delivery program. This new program utilizes the Company's proprietary automated ATM like sample management system ("MedStart") and an integrated secure web reporting portal to provide physicians visibility to their patients' adherence to chronic medication therapy.  The Platform is designed to help leading medical groups meet the requirements of emerging healthcare reform platforms.

Researchers at Harvard University, Brigham and Women's Hospital and CVS/Caremark announced the results of an important study last week indicating that up to 24% of consumers never fill their initial prescription. "While the results of this study are consistent with previous studies in the area, what is interesting is that prescription abandonment rates appear to be increasing with the growth in electronic prescribing," said Susan Hogue, VP of Managed Care Networks and Clinical Services at MedVantx.  "As Physicians embrace EHR and e-prescribing platforms, they need new tools to help insure medication therapy is initiated and adhered to on an ongoing basis.  Today, physicians have limited access to detailed data about medication samples provided and actual prescriptions filled.  MedVantx has pioneered a program that enables physicians to start all their patients on free prescription medications at the point of care thereby eliminating the potential for abandonment. As a result MedVantx is in a unique position to deliver a complete view of a specific patient's medication program from an initial medication sample to continued fulfillment of chronic medications."

MedVantx provides physicians with first ever access to a comprehensive formulary of free generic, brand, and over-the-counter medications covering chronic and complex conditions through its MedStart™ system. The MedStart™ system automates the traditional sampling process for the physician; captures physician sampling data for inclusion in the patients' claims history medical record and provides consumers access to highly relevant drug and disease state educational materials. Since patients don't always get prescriptions filled, physicians can enhance adherence by providing their patients with initial therapy and better informational tools to manage their conditions right from the office.  MedVantx also reaches out to patients to provide drug information, discuss adherence related issues and offer low-cost home delivery options.

Now with the availability of the MedVantx Patient Profile™, physicians are able to view data about how patients, on an individual basis, are complying with their prescribed medication treatments.  By showing exactly when a patient fills prescriptions, physicians can detect late refills, gaps in medication fulfillment, discontinued treatments and more to accurately access and improve patient compliance.

About MedVantx, Inc.

MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing highly relevant information to benefit patients, physicians, health plans, employers and manufacturers.  The MedVantx platform is a fully automated / integrated point of care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel - the physician's office sample closet.  The Company's consumer medication management platform includes free initial prescription and over-the-counter medication therapy at the point of care; a consumer helpline providing drug information, adherence management and reimbursement assistance and convenient consumer home delivery through its mail order pharmacy. The national MedVantx network has served over 2.5 million consumers through an integrated network including 16 health plans, 18 manufacturers and more than 3,600 prescribers.

For additional information about MedVantx and opportunities to participate in MedVantx Network, please contact MedVantx, Inc. at (858) 625-2990.

MedVantx Contact:
Susan Hogue
(858) 625-2990 Ext. 142 susan.hogue@medvantx.com


'/>"/>
SOURCE MedVantx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
2. MedVantx Honored by Inc. 500/5000 Three Years in a Row
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):